You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 1
  • AI-28 HLA-DR3 restricted responses to SMD, a lupus-related antigen provide insights to the origin of lupus-related autoantibodies and the unique features of the targeted antigens

Article info

Article menu

Download PDFPDF

Adaptive Immunity
AI-28 HLA-DR3 restricted responses to SMD, a lupus-related antigen provide insights to the origin of lupus-related autoantibodies and the unique features of the targeted antigens
Free

Authors

  • Shu Man Fu 1Division of Rheumatology and Immunology, the Centre of Inflammation, Immunity and Regenerative Medicine and Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA PubMed articlesGoogle scholar articles
  • Zhenhuan Zhao 1Division of Rheumatology and Immunology, the Centre of Inflammation, Immunity and Regenerative Medicine and Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA PubMed articlesGoogle scholar articles
  • Jiling Ren 1Division of Rheumatology and Immunology, the Centre of Inflammation, Immunity and Regenerative Medicine and Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA PubMed articlesGoogle scholar articles
  • Chao Dai 1Division of Rheumatology and Immunology, the Centre of Inflammation, Immunity and Regenerative Medicine and Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, USA PubMed articlesGoogle scholar articles
  • Felicia Gaskin 2Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA PubMed articlesGoogle scholar articles

Citation

Fu SM, Zhao Z, Ren J, et al
AI-28 HLA-DR3 restricted responses to SMD, a lupus-related antigen provide insights to the origin of lupus-related autoantibodies and the unique features of the targeted antigens
Lupus Science & Medicine 2016;3:doi: 10.1136/lupus-2016-000179.28

Publication history

  • First published August 31, 2016.
Online issue publication 
September 01, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions